Pargger H, Hampl K F, Christen P, Staender S, Scheidegger D
Department of Anesthesia, University of Basel/Kantonsspital, Switzerland.
Intensive Care Med. 1998 Aug;24(8):769-76. doi: 10.1007/s001340050664.
To determine if gastric intramucosal pH (pHi)-guided therapy reduces the number of complications and length of stay in the intensive care unit (ICU) or the hospital after elective repair of infrarenal abdominal aortic aneurysms.
Prospective, randomized study.
Surgical intensive care unit (SICU) of a University Hospital.
Fifty-five consecutive patients randomized to group 1 (pHi-guided therapy) or to group 2 (control).
Patients of group 1 with a pHi of lower than 7.32 were treated by means of a prospective protocol in order to increase their pHi to 7.32 or more.
pHi was determined in both groups on admission to the SICU and thereafter at 6-h intervals. In group 2, the treating physicians were blinded for the pHi values. Complications, APACHE II scores, duration of endotracheal intubation, fluid and vasoactive drug treatment, treatment with vasoactive drugs, length of stay in the SICU and in the hospital and hospital mortality were recorded. There were no differences between groups in terms of the incidence of complications. We found no differences in APACHE II scores on admission, the duration of intubation, SICU or hospital stay, or hospital mortality. In the two groups the incidence of pHi values lower than 7.32 on admission to the SICU was comparable (41% and 42% in groups 1 and 2, respectively). Patients with pHi lower than 7.32 had more major complications during SICU stay (p < 0.05), and periods more than 10 h of persistently low pHi values (< 7.32) were associated with a higher incidence of SICU complications (p < 0.01).
Low pHi values (< 7.32) and their persistence are predictors of major complications. Treatment to elevate low pHi values does not improve postoperative outcome. Based on these data, we cannot recommend the routine use of gastric tonometers for pHi-guided therapy in these patients. Further studies are warranted to determine adequate treatment of low pHi values that results in beneficial effects on the patient's postoperative course and outcome.
确定胃黏膜内pH值(pHi)导向治疗能否减少肾下腹主动脉瘤择期修复术后重症监护病房(ICU)或医院内的并发症数量及住院时间。
前瞻性随机研究。
大学医院的外科重症监护病房(SICU)。
55例连续患者随机分为1组(pHi导向治疗组)或2组(对照组)。
1组中pHi低于7.32的患者采用前瞻性方案进行治疗,以使pHi升高至7.32或更高。
两组患者在进入SICU时测定pHi,此后每隔6小时测定一次。在2组中,治疗医生对pHi值不知情。记录并发症、急性生理与慢性健康状况评分系统(APACHE II)评分、气管插管持续时间、液体和血管活性药物治疗情况、血管活性药物使用情况、在SICU和医院的住院时间以及医院死亡率。两组之间并发症发生率无差异。我们发现入院时APACHE II评分、插管持续时间、SICU或医院住院时间以及医院死亡率方面均无差异。两组患者进入SICU时pHi低于7.32的发生率相当(1组和2组分别为41%和42%)。pHi低于7.32的患者在SICU住院期间发生的主要并发症更多(p<0.05),持续低pHi值(<7.32)超过10小时与SICU并发症发生率较高相关(p<0.01)。
低pHi值(<7.32)及其持续存在是主要并发症的预测指标。提高低pHi值的治疗并不能改善术后结局。基于这些数据,我们不建议在这些患者中常规使用胃张力计进行pHi导向治疗。有必要进行进一步研究以确定能对患者术后病程和结局产生有益影响的低pHi值的适当治疗方法。